sign in sign up
<<
Home , Cinnamedrine, Prenylamine

COLUMBIA

36 APPROVED AND ORDERED AK 101980

Lieutenant-Governor

EXECUTIVE COUNCIL CHAMBERS, VICTORIA Jilt 10.1980

On the recommendation of the undersigned, the Lieutenant-Governor, by and with the advice and consent of the Executive Council, orders that the attached amendments and additions to the By-laws of th.. College of Pharmacists of British Columbia be approved.

11111•1111enle

ster of Health

residing Member of the Executive Council

6

(This pan is for administrative purposes and is not pall a) the Order.)

Authority under which Order is made:

Act and section _Pharmacy Act.,_Section_ka_.

Other (specify) 11-74.—r /LC__..4) 6321/2Y

statutory authority checked by-1411 2,44110-4 ....l12--/114,- 0 (31ansawl and typed orted AMENDMENTS AND ADDITIONS TO THE BY-LAWS OF THE COLLEGE OF l'ilARMACISTS

OF BRITISH COLUMBIA AS MADE BY THE COUNCIL OF THE COLLEGE AT MEETINGS

OF THE COUNCIL ON MARCH 14-16, INCLUSIVE, 1979, JUNE 14-15 INCLUSIVE,

1979, AND NOVEMBER 14-16 INCLUSIVE, 1979, AND OF THE EXECUTIVE COMMITTEE

OF THE COUNCIL ON SEPTEMBER 17, 1979, UNDER AUTHORITY OF SECTION 48 OF

THE PHARMACY ACT BEING CHAPTER 62 OF THE STATUTES OF BRITISH COLUMBIA, 1974

By-law B-2 (3) (i) is repealed and the following substituted:

"If he has been on the Retired Register for less than two years, he may resume practice by successfully completing any examination or assessment paper prescribed by the Council and by paying the current year's licence fee."

By-law B-19 (13) (b) (ii) (f) and (g) is repealed and the following substituted:

"(f) the dosage form,

(g) the cost of the ingredients and the professional fee, and

(h) the total final price charged for the posted quantity."

By-law S-32 is added as follows:

"Part I of Schedule A is amended by the deletion of:

F Actinomycin D and its deriv,.ti,,es F Amikacin F Amphntericin B and its derivatives F Bleomycin and its salts F Calcitonine F Cephalosporin C and its salts and derivatives cephalexin and cephaloridine F Chlorazepic Acid and its salts F and its salts F Colchicine F Dopramine and its salts F and its salts for internal use containing Ephedrine as the single active ingredient F Framycetin and its salts F Gentamicin F Griseofulvin Hexachlorophene and its salts when more than 0.75 per cent of hexachlorophene is present F 1-Asparaginase and its salts and derivatives F Lincomycin F Melformin and its salts and derivatives F Naprozen and its salts F Neomycin and its salts (except when sold for veterinary purposes in conformity with the requirements listed below or except as provided for in Schedule B) F NystatiL ;except in preparations for topical use on the skin) F and its salts F Piperliate and its salts F Polymixin B (except for topical use or for local action in the oral cavity or nasal passages) - 2

F Sex Hormones, except diethylstilbestrol and its salts and derivatives F Spectinomycin F Vancomycin and by the addition of:

F Actinomycin D and its salts and derivatives F Amikacin and its salts and derivatives F Amphotericin B and its salts and derivatives F Ampicillin and its salts and derivatives Apomorphine Hydrochloride Arsenic and preparations and compounds thereof for human use F L-Asparaginase and its salts and derivatives F and its salts F Benzathine Penicillin and its salts and derivatives Benztropine Mesylate Biperiden Hydrochloride F Bleomycin and its salts and derivatives F Calcitonin F Calcitriol F Carbenicillin and its salts and derivatives F Cephalosporin C and its salts and derivatives Chlorphenoxamine Hydrochloride G Chlorphentermine and its salts F Choline salicylate, when sold in combination with salicylate F Cisplatiu F Clorazepic Acid and its salts F Cloxacillin and its salts and derivatives Colchicine F Colestipol and its salts F Cycloserine Dichlorphenamide F Dicloxacillin and its salts and derivatives F Dinoprostone and its salts and derivatives F and its salts F and its salts F Econazole and its salts Ephedrine and its salts for internal use containing ephedrine as the single active ingredient F Estramustine and its salts Ethopropazine Hydrochloride F Etidronic acid and its salts F Framycetin and its salts and derivatives F Gentamicin and its salts and derivatives F Griseofulvin and its salts and derivatives F Hetacillin and its salts and derivatives F Hexachlorophene and its salts F Hydroxyurea F Lincomycin and its salts and derivatives F Megestrol and its salts F Mettormin and its salts and derivatives F Methicillin and its salts and derivatives F and its salts F Nafcillin and its salts and derivatives F Naproxen and its salts F Neomycin and its salts and derivatives (except when sold for veterinary purposes in conformity with the requirements listed below or except as provided for in Schedule B) F and its salts (except in natural substances) F Nystatin and its salts and derivatives (except preparations for topical use on the skin) F Oxacillin and its salts and derivatives G Phenternine and its salts F Piperilate and its salts 3 -

F Polymixin B and its salts and derivatives (except for topical use or for local action in the oral cavity or nasal passages) Procyclidine Hydrochloride F Sex Hormones F and its salts F Spectinomycin and its salts and derivatives F Stanozolol F Ticarcillin and its salts and derivatives F Treosulfan F Tretinoin (Vitamin A Acid) F Triazolam and its salts Trihexphenidyl Hydrochloride Tubocurarine Chloride F Valproic acid and its salts F Vancomycin and its salts and derivatives"

By-law S-33 is added as follows:

"Part II of Schedule A is deleted and is replaced by the following:

Part II

Drugs which may be sold by a pharmacist to any person after the sale is entered in the poison register and the is labelled as provided in Section 22.

Aconite and its alkaloids and their preparations, except external preparations containing less than 0.2 per cent Alkaloids - All alkaloids not specifically listed elsewhere in these Schedules Antimony Potassium Tartrate (Tartar Emetic) Areca Oil Arsenic and its preparations and compounds for veterinary use only Belladonna and its preparations and compounds, except for plasters or as provided for in Schedule B Cantharides and its derivatives and preparations Chloroform Conium and its preparations Cottonroot and its oil, derivatives and preparations Croton Oil Ether Ethyl Chloride Formaldehyde (Formant. and its preparations containing over 2 per cent formaldehyde Hyoscyamus and its preparations Lead Salts and their preparations Lobelia and its alkaloids and preparations, except internal preparations containing not more than 2 mg sulphate and external preparations containing not more than the equivalent of 400 mg of crude lobelia, or as provided for in Schedule B Mercurial Salts, except Calomel and preparations containing 5 per cent or less of Ammoniated Mercury or 2 per cent or less of Yellow Oxide of Mercury Nux Vomica and its preparations for veterinary use only Pennyroyal and its oil, derivatives and preparations Phenacetin, except in combination with other in recognized therapeutic dosage Phenol (Carbolic Acid) except in preparations of 5 per cent or less Rue and its oil, derivatives and preparations San ton in Savin and its oil, derivatives and preparations Stramonium and its preparations Strophanthus and its preparations Tansy and its oil, derivatives and preparations and its alkaloids and preparations" - 4 -

By-law S-34 is added as follows:

"The second division of Part III of Schedule A, being 'drugs that must be stored in an area of the pharmacy to which there is no public access after July 31st, 1976, and can be sold by a pharmacist to any person' is amended by the deletion of:

Cardiovascular Drugs Dimenhydrinate Epinephrine and preparations thereof

Aminophylline, except when in combination with one or more active ingredients and not exceeding 50 mg per dose Carbimazole Cycrimine HC1 Dicyclomine HC1 Di-Methionine Dyphylline Clutamic Acid HC1 Homatropine Lipotropea Mephenesin Methdilazine Oxtriphylline Phenazopyridine HC1 HC1 for ophthalmic use over 1/8 per cent Potassium Para-Aminobenzoate Lactate , except when in combination with one or more active ingredients and not exceeding 50 mg per dose

and by the addition of:

Arecoline Cycrimine Hydrochloride Dicyclomine Hydrochloride Dimenhydrinate Epinephrine and preparations thereof Clutamic Acid Hydrochloride Homatropine and its salts Isometheptene and its salts Hydrochloride Mephenesin Methdilazine Methionine Nitroglycerin Orphenadrine and its salts Phenazopyridine Hydrochloride Phenylephrine Hydrochloride for ophthalmic use over 0.125 per cent Proguanil Hydrochloride Propantheline Bromide Pyrimethamine Quinine and its salts, for internal use containing quinine as the single active ingredient Theophylline and its derivatives, except when in combination with one or more active ingredients and not exceeding 50 mg of theophylline per dose"

By-law S-35 is added as follows:

"The second division of Schedule B, being 'drugs which may be sold by non-pharmacists to any person, provided the drugs are:

(1) contained in a product which is registered as a Proprietary Medicine under Division 10 of the Regulations to the Food and Drugs Act, or - 5

(2) contained in any other product wh,n the drug concentration does not exceed that of a product registered as in (1) above and when the product is recommended to treat the same conditions as the Proprietary Medicine' is amended by the deletion of

Bentonite Blackberry Leaf Black Currant Boldo Calendula Flowers Calumba Canada Balsam Celandine Celery Centaury, Minor Centraria Islandica Chamomile Flowers Chloral Hydrate, in preparations for external use, not more than 1 per cent Chlorhydrol, when in anti-perspirant preparations Chlorobutanol Chlorothymol Chloroxylenol Coltsfoot Diastase of Malt Dichlorophene Dihydroxy-Aluminum Aminoacetate Dihydroxy-Aluminum Sodium Carbonate Eucalyptol Eucalyptus Eugenol Fumitory Herb Gentian Ginger Oleoresin Glycol Salicylate Glycyrrhiza Honey Ilorenound Hydroxypropylmethycellulose Invert Sugar Juniper Berries Juniper Tar Karaya Gum Lappa Leptandra Myrrh Oats Oil of Anise Oil of Cajeput Oil of Camphor Oil of Cinnamon Oil of Eucalyptus Oil of Hemlock Canadian 011 of Lavender Oil of Mustard Oil of Myristica Oil of Peppermint Oil of Pine Oil of Pine Needles Oil of Rosemary Oil of Sassafras Oil of Shark Liver Oil of Spearmint Oil of Thyme - 6 -

Peppermint Petrolatum Phenyl Mercuric Nitrate Pinus Sylvestris Poplar Bud Prune

and the first division of Schedule B, being 'drugs which may be sold by non-pharmacists to any person' is amended by the addition of the aforementioned drugs named in this by-law."

By-law S-36 is added as follows:

"The first division of Schedule B, being 'drugs which may be sold by non-pharmacists to any person', is amended by the deletion of:

Centrimide Merbromin Stronthium Chloride, when in dentifrices, not more than 10 per cent

Preparations containing vitamins in which the recommended daily dose is equal to or less than the amount listed below:

Vitamin A 5,000 IU Vitamin B 4.5 mg 1 Vitamin B 7.5 mg 2 Niacin 45.0 mg Niacinamide 45.0 rg Pyridoxine 3.0 mg D-pantothenic Acid 15.0 mg Folic Acid 0.1 mg Vitamin B 14.0 mcg 12 Vitamin C 150.0 mg Vitamin D 400 IU Vitamin E 25 IU

and by the addition of:

Betaine and its salts Cetrimide Choline and its salts, except choline salicylate when sold in combination with magnesium salicylate Inositol Merbromin Solution Strontium Chloride, when in dentifrices, not more than 10 per cent"

By-law S-37 is added as follows:

"Schedule B is amended by the addition of a fourth division, as follows:

Drugs which may be sold by non-pharmacists to any person, provided the drugs are:

(1) sold in the original, labelled container as packaged by the manufacturer, and

(2) labelled to identify the concentration of each drug and specific directions for use where the recommended daily dose does not exceed the amount shown, and

(3) not sold after a date on which the drug is indicated or labelled to expire.

Vitamin A 10,000 IU Vitamin B 1 - 7

Vitamin B 2 Niacin Niacinamide Pyridoxine D-pantothenic Acid Folic Acid Vitamin B 1?

Vitamin C Vitamin D 1,000 IU Vitamin E"

By-law S-38 is added as follows:

"The second division of Schedule B, being 'drugs which may be sold by non-pharmacists to any person, provided the drugs are:

(1) contained in a product which is registered as a Proprietary Medicine under Division 10 of the Regulations to the Food and Drugs Act, or

(2) contained in any other product when the drug concentration does not exceed that of a product registered as in (1) above and when the product is recommended to treat the same conditions as the Proprietary Medicine'

is amended by the deletion of:

Methapyrilene HC1."